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Objectives: Matrix metalloproteinases may play a major role in aortic wall degeneration causing abdominal aortic 
aneurysm (AAA). Available plasmin, required for MMP zymogen activation, is regulated by plasminogen activators (uPA, 
tPA) and plasminogen activator inhibitors (PAI-1, PAI-2). To appraise the impact of these regulatory proteins on aortic wall 
degeneration, expression at the level of translation and transcription was determined in human aortic smooth muscle cell 
(SMC) cultures. 
Methods: Explants were derived from aneurysmal ortic tissue (n = 6) and from three mate organ donors. Cells were also 
stimulated with 0.1-1.0 ng/ml IL-lfi. 
Results: uPA antigen and tPA antigen in the conditioned medium (CM) o/normal SMCs were not detectable but AAA 
SMCs produced uPA (values are given as median (interquartile range)), [1.97 ng/ml/lO 6cells (1.50-8.21)] and tPA [7.02 
ng/mI/lO 6cells (6.20-14.90)1. uPA antigen was absent from normal SMC cell extract (CE) but present in small amounts 
in AAA SMC CE [0.80 ng/mg protein (0.40-1.24)]. tPA was detectable in the CE of normal SMCs [3.2 ng/mg protein 
(1.90-3.40)] but at a lower concentration than in AAA SMCs [13.14 ng/mg protein (7.20-27.00)I (p < 0.05). IL-lfi 
suppressed production o/uPA and tPA in both types of SMCs. The difference in baseline PAI-1 release from normal SMCs 
and AAA SMCs was not statistically significant. Selective upregulation of PAI-1 was observed for AAA SMC after IL-lfi 
stimulation. Northern analysis o/AAA SMCs grown in serum containing medium exhibited clear bands for uPA. 
Conclusions: Human AAA SMCs are a source of elevated plasminogen activators. In the absence of a reciprocal rise of 
PAl an imbalance is created favouring proteolysis. 
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Introduction 
The fundamental structural defect in abdominal aortic 
aneurysm (AAA) wall is the disintegration f lamellar 
units caused primarily by fragmentation a d attenua- 
tion of elastin fibres. Although such degeneration 
occurs naturally in the ageing aorta, 1 the process in 
AAA is much greater and is associated with markedly 
elevated elastase 2 and collagenase activity. 3 
Increased matrix metalloproteinases (MMP) activity, 
mainly collagenase, stromelysin and gelatinase, has 
been found in AAA. 4 This group of enzymes plays a 
major role in extracellular matrix (ECM) degradation 
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under physiological and pathological conditions. 
MMP are secreted as zymogens and require activation 
5 primarily by plasmin. Plasminogen activators (PA), in 
particular urokinase-type PA, have a dual role in this 
intermediary step. Besides the conversion of plasmi- 
nogen to plasmin, uPA can also activate latent metal- 
loproteinases independently. 5 uPA, if present in 
increased amounts in the AAA wall could therefore 
contribute significantly towards accelerated protein 
degradation. 
Besides T lymphocytes, B lymphocytes and macro- 
phages which constitute the chronic inflammatory 
infiltrate ubiquitous in the AAA wall 6 SMCs are the 
only cells present in the media of normal large 
arteries. These cells are pleuripotential nd could 
therefore be a source of PAs and PAIs which in turn 
could have an influence on the integrity of the aortic 
wall in the early phases of AAA prior to the formation 
of an inflammatory infiltrate. 
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The expression of uPA, tPA, PAI-1 and PAI-2 by 
human aortic SMCs in culture from AAA and normal 
aorta was examined at the level of translation and 
transcription to appraise the impact of the plasmino- 
gen-plasmin system on the catabolic process in the 
AAA wall. Previously IL-I~ had been demonstrated in 
higher concentrations in the AAA wall compared to 
normal aorta 7and thus the effect of stimulation by this 
cytokine on SMCs was studied. 
stored at -70°C. Cells were scraped from the culture 
dish, suspended in arginine xtraction buffer (pH 4.2) 8 
and sonicated. After centrifugation at10000 rpm for 3 
min, supernatants were aliquoted and stored as 
above. 
The Bio-Rad@ assay was used for protein determi- 
nation (Bio-Rad Laboratories). Cell counts were per- 
formed using a haemacytometer with phase-contrast 
microscopy after detaching cells with 0.125% trypsin. 
The average of three counts was used. 
Materials and Methods 
Cell culture 
During surgery for elective infrarenal AAA repair, 
tissue was obtained from the anterior aspect of the 
infrarenal aorta in six male patients. The Regional 
Organ Bank of Illinois kindly provided tissue from the 
same anatomical area in three elderly male organ 
donors without aneurysmal disease. Patient age 
ranged from 53 to 78 years with controls being age 
matched. The fresh tissues were immediately placed 
in holding medium (Dulbecco's Modified Eagle's 
Medium (DME) 41%, Ham F12 41%, Fetal Bovine 
Serum 17%), kept at 4°C and explanted within 24 h. 
The adventitia nd periaortic onnective tissue were 
removed from the specimens by sharp dissection and 
the media minced into 1-2 mm fragments with a 
surgical blade. 
Explants were grown in M199 supplemented with 
10% Fetal Bovine Serum (Sigma, St. Louis, MO, 
U.S.A.), 60 ~g/ml Endothelial Cell Growth Supple- 
ment (Sigma), 120 u/ml  Penicillin G, 120 [zg/ml 
Streptomycin and 2.5 ~tg/ml Fungizone. SMCs were 
cultured in an incubator at 37°C and 5% CO2 in T25 
flasks for RNA extraction and in 12 well plates for 
immunoassay. Culture medium was changed three 
times per week. SMC morphology was confirmed by 
fluorescent, alfa-actin antibody staining. All experi- 
ments were performed on confluent cells at the 2nd to 
4th passages. 
Prior to the final experiments, cells were exposed to 
serum free conditions [DME plus insulin, transferrin, 
selenium and bovine serum albumin (Collaborative 
Biomedical, Bedford, MA, U.S.A.)] for 24 h. For a 
further 24 h period cells were stimulated with IL-lfi 
(Systems INC, Minneapolis, MN, U.S.A.) at concentra- 
tions of 0.1 ng/ml and 1.0 ng/ml. Earlier experiments 
with higher concentrations of IL-lfi did not yield 
greater stimulation than 1.0 ng/ml which led to the 
abandonment of further incremental stimulation. 
The conditioned medium (CM) was aliquoted and 
Immunoassay 
Enzyme-linked immuno-sorbent assays for total uPA, 
total tPA, PAI-1 and PAI-2 (BioPool TintElize®, Medi- 
tech, Ventura, CA) were performed on the CM and cell 
extract (CE) to quantitate the respective antigens. All 
measurements were done in triplicate. 
Northern analysis 
Total RNA extraction was done by guanidinium 
thiocyanate lysis. 9 RNA fractions were separated on a 
1% agarose gel and transferred to a nylon membrane 
by pressure blotting (PosiBlot TM by Stratagene, La 
Jolla, CA, U.S.A.). After UV cross-linking for 2 min, 
membranes were hybridised with 32p alfa-ATP (Amer- 
sham, Arlington Heights, IL, U.S.A.) labelled cDNA 
(Prime-It II, Stratagene, La Jolla, CA, U.S.A.). Freeze 
dried E. coli containing plasmids with cDNA inserts 
for uPA, tPA, PAI-1 and PAI-2, obtained from Amer- 
ican Type Culture Collection (Rockville, MD, U.S.A.), 
were used for preparation of cDNA probes. 
Hybridisation was performed using the Stratagene 
protocol for Quikhyb TM Rapid Hybridisation Solution 
(Stratagene, La Jolla, CA, U.S.A.). Autoradiographs 
were obtained by exposing the hybridised blots to 
X-ray film (Hyperrad-TM, Amersham, Arlington 
Heights, IL, U.S.A.) for 48 h at -70°C. 
Statistics 
Non-parametric statistical methods (Mann-Whitney 
U-test), to determine differences between groups at 
the 5% level were used for two reasons. The numbers 
in the two groups were relatively small and the 
distribution of the immunoassay values was markedly 
skewed. Values are given as median (interquartile 
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range). For CM values have been corrected for 106 
cells and for CE for 1 mg of protein. 
Results 
uPA and tPA secretion by normal SMCs into the CM 
was below the sensitivity of the immunoassay but 
AAA SMCs produced uPA [1.97 ng/ml/106 cells 
(1.50-8.21)] and tPA [7.02 ng/ml/106 cells 
(6.20-14.90)]. tPA was detectable in the CE of normal 
SMCs [3.2 ng/mg protein (1.90-3.40)] but at a lower 
level than in AAA SMCs [13.14 ng/mg protein 
(7.20-27.00)] (p < 0.05). uPA antigen was absent from 
normal SMC CE but present in small amounts in AAA 
SMC CE [0.80 ng/mg protein (0.40-1.24)]. 
IL-I~ stimulation significantly suppressed uPA 
release into the CM at 1.0 ng/ml (p < 0.05) but not at 
0.1 ng/ml (p = 0.054) (Fig. 1). tPA liberation was 
likewise affected at both concentrations of IL-I~ 
stimulation (Fig. 1). In the CE a similar trend was 
observed (Fig. 2) with the exception of uPA release 
which was not affected, probably due to the low 
baseline values. 
The quantities of PAI-1 in the CM was not sig- 
nificantly different between ormal SMCs [264.0 ng/ 
ml/106 cells (163.2-386.0)] and AAA SMCs [380.9 ng/ 
ml/106 cells (285.6-505.4)]. IL-I~ upregulated PAI-1 
production by AAA SMCs but there was no change in 
normal SMCs (Fig. 3). The pattern for baseline 
production of PAI-1 was repeated in the CE of AAA 
SMC [24.6 ng/mg protein (15.5-51.2)] and normal 
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Fig. 1. Bar graph demonstrating impact of IL-I~ stimulation on 
median plasminogen activator values in AAA SMC CM. * p < 0.5. 
SMC [16.5 ng/mg protein (13.8-31.1)] without any 
alteration in production after IL-I~ stimulation. In all 
experiments 1.0 ng/ml IL-I~ did not have a greater 
effect han the lower concentration f IL-I~. 
PAI-2 was detectable in two of three normal SMCs 
and in one of six AAA SMCs, CM and CE alike. Due to 
the small numbers of positive cultures and the low 
concentrations, statistical analysis was not 
performed. 
Northern analysis for uPA, tPA and PAI-1 did not 
reveal sufficient quantities of mRNA for quantitative 
comparison. Northern blot on SMCs cultured in serum 
and ECGS containing medium revealed distinct 
mRNA bands for uPA for AAA only (Fig. 4). This 
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Fig. 3. Median values of PAI-1 in AAA SMC CM and normal SMC 
CM before and after IL-1~3 stimulation. * p < 0.5. 
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phenomenon demonstrated the sensitivity of aortic 
SMCs in culture to biologically active polypeptides. 
Discussion 
SMC proliferation in the media and its migration into 
the intima result in intimal thickening in arteriosclero- 
sis and neointimal hyperplasia. 1°Controlled proteol- 
ysis of the extracellular matrix around these cells 
facilitates their movement. This ability of SMCs to lyse 
matrix protein has been demonstrated in vitro by 
cultured rat aortic SMCs which digested naturally 
produced ECM. I1 Digestion was considerably 
restricted under plasmin-free conditions indicating an 
important role for plasmin. Plasmin, a non-specific 
serine protease, efficiently cleaves other matrix pro- 
teins besides fibrinogen. This property is exemplified 
by its ability to digest 75% of an ECM layed down by 
bovine SMCs in culture. 
The proenzyme plasminogen is produced by cells 
and requires activation to plasmin by uPA and tPA 
prior to attaining full proteolytic activity. Both uPA 
and tPA expression by SMCs has been demonstrated 
in a rat model of arterial injury. 12 Low levels of tPA 
and uPA activity are present in the normal rat carotid 
artery but increase following endothelial denudation. 
Maximum uPA activity was reached within 24 h 
corresponding to SMC proliferation, tPA increased 
during cell migration and reached maximum levels at 
7 days. la 
Monocyte-like cells and certain tumour cells make 
use of cell surface-localised proteolysis to penetrate 
tissue barriers during migration, uPA and its cell 
surface receptor (uPAR) play a pivotal role in the lyric 
process, uPA is secreted by cells in a single-chain form 
which is resistant o PAI. Binding of uPA to its cell 
membrane receptor not only confines the extent and 
location of proteolysis but also results in phosphoryla- 
tion of uPA which reduces reactivity to PAI by 60%.13 
It is therefore not surprising that an unfavourable 
prognosis has been associated with uPA expression by 
some malignant cells for instance colon cancer 14 and 
prostate cancer. 15 
In contrast to arteriosclerosis, SMC proliferation and 
migration are not prominent features of aneurysmal 
dilatation. In fact, SMCs are often diminished in the 
AAA wall with patches of media with the most 
pronounced estruction of lamellar units being com- 
pletely devoid of SMCs. 16 Our in vitro study has 
demonstrated that under normal circumstances uPA 
and tPA are not produced by aortic SMCs but that 
both PAs are expressed in AAA. We suggest hat in 
this model of disproportionate matrix degradation 
and deposition, SMCs take part in a proteolytic 
cascade in which PAs and plasmin are of importance. 
Interaction between inflammatory cells, fibroblasts 
and SMCs could create an environment conducive to 
proteolytic destruction of the aortic wall. 
Such a system of tissue interaction has been demon- 
strated among fibroblasts, which secrete interstitial 
collagenase and stromelysin as proenzymes, and 
keratinocytes, which secrete uPA, in the final activa- 
tion of human interstitial collagenaseF This uPA- 
plasminogen-dependent pathway is required to fully 
activate interstitial collagenase by C-terminal cleavage 
of partially activated collagenase. The r action is 
completely abolished by the addition of anti-uPA 
antibody. 17 
Activated lymphocytes and macrophages constitute 
the chronic inflammatory infiltrate which is a con- 
sistent histologic entity in the AAA wall. Elastin 
fragments, especially the sections rich in cross-linking 
which are particularly abundant in the AAA wall, are 
chemotactic for mononuclear inflammatory cells. ~8 In 
this respect uPA and not tPA may also have an 
influence on the inflammatory infiltrate. Purified uPA 
stimulated human peripheral blood neutrophil chem- 
otaxis under experimental conditions which was 
completely inhibited by adding anti-uPA-antibody. 19 
By elaborating a wide array of cytokines, inflamma- 
tory cells regulate the local microenvironment. By 
modulating the differentiation of SMCs and other 
28 S 
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Fig. 4. uPA mRNA bands for AAA SMCs cultured in serum and ECGS containing medium. 
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cells, a delicate balance between activators and inhibi- 
tors of proteolysis could either enhance matrix protein 
digestion or favour healing by collagen deposition. To 
date, IL-I~ is the only cytokine which has been 
demonstrated in higher concentrations in the AAA 
wall compared with normal aorta. 7 IL-I~ secretion 
takes place during the initial phase of inflammation 
and decreases as monocyte infiltration stabilises. The 
total effect of IL-I~ stimulation in our study appeared 
to be a suppression of proteolysis as PA release was 
decreased and PAI-1 production was up-regulated. 
The cytokine profile for AAA has not yet been 
qualified or quantified which leaves a void with 
regard to the combined effect of two or more cytokines 
in various concentrations on AAA SMC function. 
Combinations of cytokines have been shown to have 
opposite ffects to that of the individual hormones. 2°
Depending on the cell type, various cytokines exhibit 
stimulatory effects. PA activity from cultured rat 
calvarial cells was elevated after incubation with 
acidic fibroblast growth factor, basic fibroblast growth 
factor, epidermal growth factor and platelet-derived 
growth factor. 21 
Reilly et aI. have reported higher extractable tPA 
antigen and to a lesser extent uPA antigen in AAA 
compared with occlusive aortic disease. 22 The ele- 
vated PA status in AAA was ascribed to migrant cells 
as uPA expression was localised to cells within the 
inflammatory infiltrate. Our study has not only 
revealed upregulation of PA in AAA but also that this 
increase can in part be attributed to resident SMCs. It 
is possible that resident SMCs are stimulated to 
increased PA production in the early phase of AAA 
prior to the establishment of an inflammatory infil- 
trate. In the absence of a reciprocal rise in PAI the net 
effect is greater zymogen plasmin activation which in 
turn enhances elastase and collagenase activity. 
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